Restoring cardiac function: an emerging spectrum of therapeutic options
Related Experiment Videos
1L.VAD, Inc./Surgical Research Laboratory, Sinai Hospital of Detroit, MI 48235.
Insights
Restoring cardiac function involves various techniques. In-series assist devices offer reliable, long-term support for specific heart failure patients, with advantages in management and deactivation.
Area of Science:
- Cardiovascular Medicine
- Biomedical Engineering
- Surgical Innovation
Background:
- Congestive heart failure (CHF) presents diverse challenges requiring advanced therapeutic strategies.
- Current treatments like cardiac transplantation and total artificial hearts address specific patient subsets.
- Left-sided CHF necessitates methods to augment cardiac output.
Purpose of the Study:
- To review emerging techniques for restoring cardiac function.
- To compare the efficacy and reliability of parallel-assist versus in-series assist devices for CHF.
- To highlight the advantages of in-series techniques in specific patient populations.
Main Methods:
- Review of current and emerging cardiac assist technologies.
- Comparative analysis of hemodynamic augmentation between parallel and in-series assist methods.
- Evaluation of reliability, management simplicity, and long-term clinical efficacy.
Main Results:
- Cardiac transplantation and total artificial hearts offer solutions for select CHF patients.
- Parallel-assist techniques maximally augment cardiac output for left-sided CHF.
- In-series techniques provide reliable support for patients without major arrhythmias, offering deactivation capability.
Conclusions:
- In-series assist devices present a reliable option for specific CHF patients, with simpler management and proven long-term efficacy.
- While offering less hemodynamic augmentation than parallel assist, in-series methods provide greater intrinsic reliability.
- The ability to deactivate in-series support temporarily without increased risk is a significant advantage.
Abstract:
A spectrum of techniques for restoring cardiac function is emerging. Among patients with global congestive heart failure (CHF), cardiac transplantation may help a small minority for whom allografts are available; the total artificial heart may eventually benefit a larger number. For patients with left-sided CHF, parallel-assist techniques maximally augment cardiac output. In-series techniques can help others without major arrhythmias and some residual cardiac output. As compared with parallel assist, in-series methods offer lesser hemodynamic augmentation but greater intrinsic reliability and the possibility of deactivation of support for hours or days without increased risk. Additional advantages include simplicity of management and documented long-term clinical efficacy.